Skip to main
ENTA
ENTA logo

Enanta Pharmaceuticals (ENTA) Market Capitalization Overview

Market Cap: $160.33M as of Jun 13, 2025

$160.33M
Past Month+$45.77M (39.95%)
As of Jun 13, 2025, Enanta Pharmaceuticals (ENTA) has a market capitalization of $160.33M. Over the past 30 days, its market cap has increased by 4.18%, while in the last 12 months, it has increased by 31.56%.

Market capitalization represents the total value of Enanta Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Enanta Pharmaceuticals (ENTA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Enanta Pharmaceuticals (ENTA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Enanta Pharmaceuticals (ENTA) Market Cap History

DateMarket CapChange
Jun 2, 2025$134.46M+4.18%
May 1, 2025$129.07M+13.72%
Apr 1, 2025$113.49M-27.42%
Mar 3, 2025$156.37M+41.78%
Feb 3, 2025$110.29M-6.91%
Jan 2, 2025$118.48M-34.77%

Enanta Pharmaceuticals (ENTA) End of Year Market Cap History

DateMarket CapChange
2025$160.33M+31.56%
2024$121.87M-38.50%
2023$198.17M-79.52%
2022$967.50M-36.34%
2021$1.52B+79.80%
2020$845.33M

FAQs About Enanta Pharmaceuticals (ENTA) Market Cap

As of Jun 13, 2025, the market capitalization of Enanta Pharmaceuticals (ENTA) is $160.33M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Enanta Pharmaceuticals’s market capitalization has increased by 39.95%, changing from $114.56M to $160.33M as of Jun 13, 2025.

In the last 3 months, Enanta Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Enanta Pharmaceuticals’s market capitalization decreased from $198.17M in January to $121.87M in December, reflecting a -38.5% change.

In the past five years, Enanta Pharmaceuticals (ENTA) has had a compound annual growth rate (CAGR) of -32.12% in market capitalization. This means its market cap has shrunk at an average rate of -32.12% per year.

Enanta Pharmaceuticals (ENTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.